We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STM:NYSESTMicroelectronics N.V. Analysis

Data as of 2026-09-03 - not real-time

$50.27

Latest Price

9/10Risk

Risk Level: High

Executive Summary

STMicroelectronics N.V. trades at $50.27, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has lost 6.0%. RSI sits at 42.3, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at $48.48 up to resistance at $57.04.
Valuation screens as undervalued: a P/E of 19.8 sits below the sector average of 35.4. The average analyst target implies 49.3% above today's level. Revenue is growing at 26.1% on a 3.6% profit margin. The 0.71% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 54.5%, a beta of 2.71 and a maximum drawdown of 39.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on buy — conviction 7 out of 10.

Top Market Events

STMicroelectronics NV STM reports robust revenue growth across key segments, despite facing manufacturing and supply...Yahoo Finance1monSTMicroelectronics N.V. STM Q2 FY2026 earnings call transcriptSTM delivered Q2 2026 net revenues of...Benzinga.com1monSTMicroelectronics Earnings & ForecastsSTMicroelectronics STM last issued guidance on July 23, 2026 for...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 45.15
  • MACD momentum is positive
  • 30-day price change of -6.0%

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 19.8 versus sector average of 35.4
  • Trading above the 200-day average of 45.15
  • Analyst targets imply +49.3% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 19.8 versus sector average of 35.4
  • Analyst targets imply +49.3% versus the current price
  • Revenue growth of +26.1%

Key Metrics & Analysis

Financial Health

Revenue Growth26.10%
Profit Margin3.56%
P/E Ratio19.8
ROE2.69%
ROA2.03%
Debt/Equity23.45
P/B Ratio2.5
Op. Cash Flow$2.3B
Free Cash Flow$91.0M
Industry P/E35.4

Technical Analysis

TrendNeutral
RSI42.3
Support$48.48
Resistance$57.04
MA 20$51.83
MA 50$58.41
MA 200$45.15
MACDBullish
VolumeDecreasing
Fear & Greed Index94.73

Valuation

Fair Value$5.53
Target Price$75.04
Upside/Downside49.28%
GradeUndervalued
TypeGrowth
Dividend Yield0.71%

Risk Assessment

Beta2.71
Volatility54.48%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.